Financings in Brief: Ballard Medical Products
This article was originally published in The Gray Sheet
Executive SummaryBallard Medical Products: Draper, Utah-based disposable hospital products manufacturer enters an agreement to pay $2 mil. for a 19.5% preferred equity stake in Neuro Navigational Corporation. Costa Mesa, California-based NNC, which had 1994 sales of $881,000, markets disposable microendoscopes with fiberoptic imaging capability for use in minimally invasive brain surgery. The firm also is developing products for vascular surgery. Under the deal, Ballard gains a two-year option to acquire all of the assets of NNC. Ballard says its investment in NNC will diversify its technology base and offer "the potential for Ballard to be the market leader in the rapidly growing minimally invasive segments of neurosurgery and vascular surgery"...
You may also be interested in...
TTS Pharma CEO Mark Tucker discusses his ambition to bring a legal CBD oil to the UK market, following the recent submission of a European Union novel food application.
Italy Round-Up: Mylan And Polifarma Strike Deal, OTC Market Stable, Cholesterol-Lowering Probiotic Launch
The latest news from Italy's OTC and supplements markets, including the latest sales figures, business deals, product launches, ad regulation and local association activities.
Sandoz CEO Richard Saynor has pledged that the company will ensure stable pricing for essential coronavirus-related medicines amid concerns over how the outbreak will affect the supply chain.